SEC 13F Intelligence

Managers / Q2 2019 · view latest →

PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE

CIK 0001047859 · 500 CRESCENT COURT, SUITE 260, DALLAS, TX, 75201 · 2148713700

Reported Value
$130M
Q2 2019
Positions
25
Filings on Record
29
2019–present window
Filed
Aug 14, 2019
original filing

Summary

Paragon Associates & Paragon Associates II Joint Venture reported $130M in U.S.-listed holdings across 25 positions for Q2 2019.

Its largest position, Reata Pharmaceuticals, represents 17.8% of the portfolio.

Compared with Q1 2019, the fund opened 7 new positions and exited 12.

Portfolio Metrics

Turnover
+21.8%
vs prior filed quarter
Top-10 Concentration
+71.7%
share of reported value
Largest Position
+17.8%
Reata Pharmaceuticals
New / Exited
7 / 12
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $106MQ1 ’19Q2 ’19: $130MQ3 ’19: $130MQ4 ’19: $178MQ1 ’20: $93MQ1 ’20Q2 ’20: $91MQ3 ’20: $74MQ4 ’20: $65MQ1 ’21: $66MQ1 ’21Q2 ’21: $75MQ3 ’21: $88MQ4 ’21: $63MQ1 ’22: $54MQ1 ’22Q2 ’22: $51MQ3 ’22: $50MQ4 ’22: $54MQ1 ’23: $48MQ1 ’23Q2 ’23: $49MQ3 ’23: $31MQ4 ’23: $44MQ1 ’24: $56MQ1 ’24Q2 ’24: $41MQ3 ’24: $56MQ4 ’24: $43MQ1 ’25: $43MQ1 ’25Q2 ’25: $63MQ3 ’25: $56MQ4 ’25: $48MQ1 ’26: $74MQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 96.8%Other: 1.6%US DOMESTIC: 1.5%
  • Common Stock · 96.8% · $126M
  • Other · 1.6% · $2M
  • US DOMESTIC · 1.5% · $2M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
HUMHUMANA INCNEW+45.0K45.0K+$12M$12M
OXYOCCIDENTAL PETE CORPNEW+200.0K200.0K+$10M$10M
CICIGNA CORP NEWNEW+35.0K35.0K+$6M$6M
ELVANTHEM INCNEW+12.5K12.5K+$4M$4M
CFCF INDS HLDGS INCNEW+75.0K75.0K+$4M$4M
DVNDEVON ENERGY CORP NEWNEW+45.0K45.0K+$1M$1M
ABBVABBVIE INCNEW+10.0K10.0K+$727,000$727,000
URIUNITED RENTALS INCSOLD OUT−30.0K0−$3M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2019

25 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1REATA PHARMACEUTICALS INCCL A17.80%$23M245.0K
2HUMHUMANA INChistory →COM9.20%$12M45.0K
3OXYOCCIDENTAL PETE CORPhistory →COM7.75%$10M200.0K
4NEMNEWMONT GOLDCORP CORPORATIONhistory →COM7.41%$10M250.0K
5NVGSNAVIGATOR HOLDINGS LTDhistory →SHS7.09%$9M982.9K
6ABXBARRICK GOLD CORPORATIONhistory →COM4.86%$6M400.0K
7PARRPAR PACIFIC HOLDINGS INChistory →COM NEW4.74%$6M300.0K
8IRIXIRIDEX CORPhistory →COM4.63%$6M1.32M
9CICIGNA CORP NEWhistory →COM4.25%$6M35.0K
10DHXDHI GROUP INChistory →COM3.99%$5M1.45M
11MHKMOHAWK INDS INChistory →COM3.41%$4M30.0K
12WPMWHEATON PRECIOUS METALS CORPhistory →COM3.26%$4M175.0K
13EPSNEPSILON ENERGY LTDhistory →COM3.13%$4M1.08M
14AEMAGNICO EAGLE MINES LTDhistory →COM2.96%$4M75.0K
15ELVANTHEM INChistory →COM2.72%$4M12.5K
16CFCF INDS HLDGS INChistory →COM2.70%$4M75.0K
17AGIALAMOS GOLD INC NEWhistory →COM CL A2.33%$3M500.0K
18COMMUNITY BANKERS TR CORPCOM1.63%$2M250.0K
19FORESTAR GROUP INCNOTE 3.750% 3/01.54%$2M2.00M
20WPX ENERGY INCCOM1.11%$1M125.0K
21HRIHERC HLDGS INChistory →COM1.06%$1M30.0K
22DVNDEVON ENERGY CORP NEWCOM0.99%$1M45.0K
23CDNACAREDX INCCOM0.69%$900,00025.0K
24ABBVABBVIE INCCOM0.56%$727,00010.0K
25TUESDAY MORNING CORPCOM NEW0.21%$277,000163.7K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$74M14May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$48M12Feb 12, 202613F-HRchanges · EDGAR ↗
Q3 2025$56M12Nov 12, 202513F-HRchanges · EDGAR ↗
Q2 2025$63M15Aug 13, 202513F-HRchanges · EDGAR ↗
Q1 2025$43M13May 13, 202513F-HRchanges · EDGAR ↗
Q4 2024$43M12Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$56M16Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$41M11Aug 13, 202413F-HRchanges · EDGAR ↗
Q1 2024$56M16May 14, 202413F-HRchanges · EDGAR ↗
Q4 2023$44M15Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$31M10Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$49M13Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$48M11May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$54M17Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022$50M12Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$51M11Aug 16, 202213F-HRchanges · EDGAR ↗
Q1 2022$54M7May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$63M10Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$88M17Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$75M16Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$66M11May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$65M10Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$74M8Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$91M10Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$93M13May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$178M19Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$130M21Nov 13, 201913F-HRchanges · EDGAR ↗
Q2 2019$130M25Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$106M30May 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.